Article
Receptor conversion in metastatic breast cancer: analysis of 390 cases from a single institution.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc - 1 Dec 2020
Chen Rong, Qarmali Morad, Siegal Gene P, Wei Shi
Abstract excerpt
Estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor-2 (HER2) status provide clinical utility in guiding therapeutic decision-making in metastatic breast cancer (BC). Increasing data have shown substantial differences between the receptor profiles of primary BCs and their paired metastases. In this study, we provide a large single center cohort to assess the frequency of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
